Patient characteristic | Median (IQR) or n (%) |
---|---|
Age, years | 49.0 (38.0–55.0) |
Female, n | 41.0 (77.4%) |
Last known EDSS scorea | 2.0 (1.5–3.3) |
Time since diagnosis, yearsb | 6.5 (3.0–12.0) |
Duration of therapy, monthsc | 47.0 (30.8–96.3) |
Duration of therapy with sc IFN β-1a, months | 24.0 (20.0–36.0) |
Patients with relapse during past 9 months, n | 8.0 (15.1%) |